Jaguar Health (JAGX) announced that the company plans to pursue approval from the European Medicines Agency’s Committee for Veterinary Medicinal Products for Canalevia in the European Union for ...

Kashiv BioSciences has reported encouraging topline outcomes from the randomised confirmatory trial of the proposed ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be authorised to treat unresectable ...

To this day, the UN estimates that one person dies from AIDs every single minute - despite the fact that effective treatement ...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025; Marks the ...

New appointees with BDO Ireland, A&L Goodbody, Ekco, European Union Drugs Agency, Irish Human Rights and Equality Commission and Transport Infrastructure Ireland ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the. On June 23, TD Cowen analyst Tyler Van Buren began coverage of the com ...

Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval.

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL.